FHIR
© HL7.org |
FHIRsmith
4.0.1 |
Server Home
|
XIG Home
|
XIG Stats
|
FHIR IG analytics
Version:
All
|
R2
|
R2B
|
R3
|
R4
|
R4B
|
R5
|
R6
Authority:
All
|
hl7
|
ihe
|
national
Realm:
All
|
au
|
be
|
br
|
ca
|
ch
|
cl
|
cr
|
cz
|
de
|
dk
|
ee
|
eu
|
fi
|
fr
|
il
|
in
|
it
|
jp
|
kr
|
nl
|
no
|
nz
|
pl
|
pt
|
se
|
stt
|
tw
|
uk
|
us
|
uv
View:
All
|
Resource Profiles
|
Datatype Profiles
|
Extensions
|
Logical Models
|
CodeSystems
|
ValueSets
|
ConceptMaps
Resources - All Kinds, Realm US
21,577 resources (
JSON
|
CSV
)
Type:
Account
ActivityDefinition
ActorDefinition
AdministrableProductDefinition
AdverseEvent
AllergyIntolerance
Appointment
AppointmentResponse
ArtifactAssessment
AuditEvent
Basic
Binary
BiologicallyDerivedProduct
BiologicallyDerivedProductDispense
BodySite
BodyStructure
Bundle
CapabilityStatement
CarePlan
CareTeam
CatalogEntry
ChargeItem
ChargeItemDefinition
Citation
Claim
ClaimResponse
ClinicalImpression
ClinicalUseDefinition
CodeSystem
Communication
CommunicationRequest
Composition
ConceptMap
Consent
Contract
Coverage
CoverageEligibilityRequest
CoverageEligibilityResponse
DetectedIssue
Device
DeviceDefinition
DeviceDispense
DeviceMetric
DeviceRequest
DeviceUsage
DeviceUseStatement
DiagnosticReport
DocumentManifest
DocumentReference
Encounter
EncounterHistory
Endpoint
EnrollmentRequest
EnrollmentResponse
EpisodeOfCare
Evidence
EvidenceVariable
ExampleScenario
ExplanationOfBenefit
FamilyMemberHistory
Flag
GenomicStudy
Goal
GraphDefinition
Group
GuidanceResponse
HealthcareService
ImagingSelection
ImagingStudy
Immunization
ImmunizationEvaluation
ImmunizationRecommendation
ImplementationGuide
Ingredient
InsurancePlan
InsuranceProduct
InventoryItem
InventoryReport
Invoice
Library
Linkage
List
Location
ManufacturedItemDefinition
Measure
MeasureReport
Media
Medication
MedicationAdministration
MedicationDispense
MedicationKnowledge
MedicationRequest
MedicationStatement
MedicinalProductDefinition
MedicinalProductManufactured
MessageDefinition
MessageHeader
MolecularDefinition
MolecularSequence
NamingSystem
NutritionOrder
Observation
ObservationDefinition
OperationDefinition
OperationOutcome
Organization
OrganizationAffiliation
PackagedProductDefinition
Parameters
Patient
PaymentNotice
PaymentReconciliation
Permission
Person
PersonalRelationship
PlanDefinition
Practitioner
PractitionerRole
Procedure
ProcedureRequest
Provenance
Questionnaire
QuestionnaireResponse
ReferralRequest
RegulatedAuthorization
RelatedPerson
RequestGroup
RequestOrchestration
Requirements
ResearchStudy
ResearchSubject
RiskAssessment
Schedule
SearchParameter
ServiceRequest
Slot
Specimen
SpecimenDefinition
StructureDefinition
StructureMap
Subscription
SubscriptionStatus
SubscriptionTopic
Substance
SubstanceDefinition
SupplyDelivery
SupplyRequest
Task
TerminologyCapabilities
TestPlan
TestReport
TestScript
Transport
ValueSet
VerificationResult
VisionPrescription
Text:
Package:
Only Show Used
By Version
R2
: 0
R2B
: 0
R3
: 578
R4
: 19,982
R4B
: 194
R5
: 823
R6
: 0
By Authority
none: 2,208
hl7
: 19,367
national
: 2
Start
Prev
Rows 8400 - 8600
Next
Package
Version
Identity
Name/Title
Status
FMM
WG
Date
Auth
Usage #
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.812.json
Hip Osteoarthritis
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.813.json
Hip joint surgery CPT
active
2024-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.814.json
Hip joint surgery SCT
active
2024-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.815.json
Hip joint surgery
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.816.json
Osteoarthritis of right hip I10
active
2024-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.817.json
Osteoarthritis of left hip I10
active
2024-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.818.json
Osteoarthritis of right hip SCT
active
2024-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.819.json
Osteoarthritis of left hip SCT
active
2024-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.820.json
Osteoarthritis of right hip
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.821.json
Osteoarthritis of left hip
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.823.json
Aminoglycosides
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.824.json
Carbapenems
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.826.json
Monobactams
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.827.json
Penicillins
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.828.json
Antimycobacterials
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.829.json
Beta_lactamase
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.830.json
Cyclic lipopeptides
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.831.json
Lincosamides
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.832.json
Macrolides
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.833.json
Amphenicol
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.834.json
Oxazolidinones
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.835.json
Fluoroquinolones
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.836.json
Sulfonamides
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.837.json
Tetracyclines
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.838.json
Phosphonics
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.839.json
Pleuromutilin
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.840.json
Streptogramins
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.841.json
Lipoglycopeptides
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.842.json
Nitroimidazoles
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.843.json
PIM_Hyd_Bus_Mir_Tra
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.844.json
Nitrofurans
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.845.json
Rifamycins
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.846.json
Glycylcycline
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.847.json
Pyrimidines
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.849.json
Antibiotics oral and parenteral
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.850.json
Medications_hyperkalemia
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.852.json
Hyperkalemia_ICD10
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.853.json
Hyperkalemia_SCT
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.854.json
Hyperkalemia Conditions
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.855.json
Medications_Chronic Hyperkalemia
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.858.json
PIM_Alpha_Blockers_2
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.860.json
PIM_Ambulatory_Visits_CPTs
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.862.json
PIM_Ambulatory_Visits_SNOMED
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.863.json
PIM_Thyroid_Stimulating_Hormone_(TSH)
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.864.json
PIM_Triiodothyronine_(T3)
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.865.json
PIM_Thyroxine_(T4)
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.866.json
PIM_Magnesium_LOINC
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.867.json
PIM_BMP_CMP_LOINC
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.868.json
PIM_URIC_ACID_LOINC
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.869.json
PIM_Migraine_Medications
active
2025-04
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.870.json
PIM_Triptans
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.871.json
ICS_SABA Reliever
active
2024-06
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.873.json
PIM_Asthma_COPD_Meds
active
2025-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.874.json
PIM_Lipid_Panel_CPTs
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.875.json
PIM_Hepatic_Function_Panel_CPTs
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.876.json
Alpha Glucosidase Allergy Intolerance
active
2025-04
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.877.json
Inflammatory bowel disease I10
active
2024-04
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.878.json
Inflammatory bowel disease SCT
active
2024-04
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.879.json
Inflammatory bowel disease
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.880.json
Gastrointestinal obstruction SCT
active
2024-04
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.881.json
Gastrointestinal obstruction I10
active
2024-04
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.882.json
Gastrointestinal obstruction
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.883.json
DPP4i Allergy Intolerance
active
2025-04
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.884.json
Multiple endocrine neoplasia type 2 (MEN II) SCT
active
2024-04
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.885.json
Multiple endocrine neoplasia type 2 (MEN II) I10
active
2024-04
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.886.json
Multiple endocrine neoplasia type 2 (MEN II)
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.887.json
Gastroparesis SCT
active
2024-04
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.888.json
Gastroparesis I10
active
2024-04
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.889.json
Gastroparesis
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.890.json
Meglitinide Allergy Intolerance
active
2025-04
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.891.json
Sulfonylurea Allergy Intolerance
active
2025-04
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.892.json
Peripheral edema I10
active
2024-04
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.893.json
Peripheral edema SCT
active
2024-04
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.894.json
Peripheral edema
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.895.json
TZD Allergy Intolerance
active
2025-05
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.896.json
PIM_Beta_Blockers
active
2024-11
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.897.json
PIM_CCB_DHPs
active
2024-11
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.898.json
PIM_Loop_Diuretics
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.899.json
PIM_Inhaled_Corticosteroids_(ICS)
active
2025-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.9.json
ACE inhibitors
active
2024-12
hl7
3
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.90.json
ASCVD I10
active
2023-09
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.900.json
PIM_Leukotrienes
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.901.json
OIA_Asthma_COPD_Meds_Inhalers
active
2025-04
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.902.json
OIA_Asthma_COPD_Meds_Nebulizers
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.903.json
OIA_Asthma_COPD_Meds_Oral
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.904.json
OIA_GLP1_Injectables
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.905.json
OIA_Insulin_Injectables
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.906.json
OIA_Oral_Hypoglycemics
active
2024-12
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.907.json
OIA_DM1_DM2_Meds
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.908.json
Medium Dose ICS Formoterol
active
2024-05
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.909.json
High Dose ICS Formoterol
active
2024-05
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.910.json
CKD stage5OrESRD I10
active
2024-05
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.911.json
CKD stage5OrESRD SCT
active
2024-05
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.912.json
CKD stage5OrESRD
active
2024-05
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.914.json
Anxiety_I10
active
2024-06
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.915.json
Anxiety_SCT
active
2024-06
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.916.json
Anxiety
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.918.json
Stress_SCT
active
2024-06
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.919.json
Stress_I10
active
2024-06
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.920.json
Stress
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.921.json
PBH_Anxiety_SCT
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.922.json
PBH_Depression_SCT
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.923.json
PBH_Stress_SCT
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.924.json
PBH_Insomnia_SCT
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.925.json
PIM_CMP_CPTs
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.926.json
Canagliflozin meds
active
2024-07
hl7
3
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.927.json
Empagliflozin meds
active
2024-07
hl7
3
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.928.json
Dapagliflozin meds
active
2024-07
hl7
2
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.929.json
Ertugliflozin meds
active
2024-07
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.930.json
Dulaglutide meds
active
2024-07
hl7
3
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.931.json
Liraglutide meds
active
2024-07
hl7
3
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.932.json
Semaglutide SC meds
active
2024-07
hl7
3
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.933.json
T2DM meds benefitting ASCVD
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.934.json
T2DM meds benefitting CKD stages 2, 3, and 4 with eGFR >= 20 mL/min
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.935.json
T2DM meds benefitting CKD stage 5
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.936.json
T2DM meds benefitting HF with eGFR >= 20 mL/min
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.938.json
Crohn disease SCT
active
2024-10
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.939.json
Crohn disease I10
active
2024-10
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.940.json
Crohn disease
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.941.json
Celiac disease SCT
active
2024-10
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.942.json
Celiac disease I10
active
2024-10
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.943.json
Celiac disease
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.944.json
OIA_Bisoprolol
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.945.json
OIA_PVD_ICD10
active
2024-10
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.946.json
Vibration Controlled Transient Elastography (VCTE)
active
2024-12
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.947.json
OIA_Antihypertensive_Medications
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.950.json
OIA_CAD_ICD10
active
2024-10
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.951.json
OIA_DM_ICD10
active
2024-10
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.952.json
OIA_Creatinine_Levels_LOINC
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.953.json
OIA_DM_SNOMEDCT
active
2024-10
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.954.json
OIA_CAD_SNOMEDCT
active
2024-10
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.955.json
OIA_PVD_SNOMEDCT
active
2024-10
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.956.json
OIA_DM_ICD10_SNOMEDCT
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.957.json
OIA_CAD_ICD10_SNOMEDCT
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.958.json
OIA_PVD_ICD10_SNOMEDCT
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.959.json
ACEi for HFrEF
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.960.json
ARB for HFrEF
active
2024-12
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.961.json
OIA_AntiHTN_Meds_Inclusion_List
active
2024-11
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.962.json
OIA_Thiazide_Diuretics
active
2024-11
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.963.json
OIA_RFs_ACS_ICD10
active
2024-12
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.964.json
OIA_RFs_ACS_SNOMED
active
2024-12
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.965.json
OIA_RFs_ACS__ICD10_SNOMED
active
2024-12
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.966.json
OIA_Aortic_Calcifications_ICD10
active
2025-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.967.json
OIA_Aortic_Calcifications_SNOMED
active
2025-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.968.json
OIA_Aortic_Calcifications_ICD10_SNOMED
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.969.json
OIA_Microalbumin
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.97.json
Sulfonylurea AllergyIntolerance SCT
active
2023-09
hl7
2
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.970.json
OIA_LDL_Cholesterol
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.971.json
Pioglitazone
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.972.json
MASLD I10
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.973.json
MASLD SCT
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.975.json
OIA_Sulfonylureas
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.978.json
OIA_RFs_ASCVD_ICD10
active
2025-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.979.json
OIA_RFs_ASCVD_SNOMED
active
2025-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.98.json
BMI LOINC
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.980.json
OIA_RFs_ASCVD_ICD10_SNOMED
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.981.json
OIA_TIA_ICD10
active
2025-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.982.json
OIA_TIA_SNOMED
active
2025-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.983.json
OIA_TIA_ICD10_SNOMED
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.984.json
OIA_Angina_ICD10
active
2025-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.985.json
OIA_Angina_SNOMED
active
2025-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.987.json
OIA_Angina_ICD10_SNOMED
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.988.json
OIA_Ischemic_Hemorrhagic_Stroke_ICD10
active
2025-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.989.json
OIA_Ischemic_Hemorrhagic_Stroke_SNOMED
active
2025-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.990.json
OIA_Ischemic_Hemorrhagic_Stroke_ICD10_SNOMED
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.991.json
OIA_Myocardial_Infarction_ICD10
active
2025-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.992.json
OIA_Myocardial_Infarction_SNOMED
active
2025-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.993.json
OIA_Myocardial_Infarction_ICD10_SNOMED
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.995.json
OIA_PAD_ICD10
active
2025-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.996.json
OIA_PAD_SNOMED
active
2025-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.997.json
OIA_PAD_ICD10_SNOMED
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.998.json
OIA_Coronary_Arterial_Revascularization
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1080.5.json
Contact or Office Visit
active
2022-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1080.6.json
Contact or Office Visit
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1080.7.json
Contact or Office Visit
active
2022-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.10.json
Nutrition Diagnosis SNOMED CT
active
2025-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.101.json
Hospice Status
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.14.json
Vitamin Mineral Supplement and Bioactive Substance Management SNOMED CT
active
2020-08
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.17.json
Pediatric Enteral Formulas SNOMED CT
active
2021-04
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.18.json
Modified Amino Acid Formulas SNOMED CT
active
2024-04
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.19.json
Nutrition Counseling Approach and Strategies SNOMED CT
active
2020-09
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.20.json
Enteral Nutrition Management SNOMED CT
active
2020-09
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.21.json
Nutrition Assessment
active
2024-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.25.json
Nutritional Status Severely Malnourished
active
2016-12
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.30.json
Malnutrition Risk Screening
active
2015-11
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.31.json
Malnutrition At Risk
active
2015-11
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.32.json
Malnutrition Risk Screening
active
2016-12
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.34.json
Malnutrition Screening Finding of Not At Risk Result
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.35.json
Malnutrition Screening Not at Risk
active
2015-11
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.38.json
Malnutrition Screening Finding of At Risk Result
active
2025-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.39.json
Malnutrition Risk Screening
active
2016-12
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.40.json
Malnutrition Risk Screening
active
2022-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.41.json
Nutritional Status Severely Malnourished
active
2025-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.42.json
Nutrition Assessment Status Finding of Severely Malnourished
active
2024-12
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.43.json
Nutrition Assessment Status Finding of Severely Malnourished
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.44.json
Nutrition Assessment Status Finding of Moderately Malnourished
active
2024-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.45.json
Nutritional Status Moderately Malnourished
active
2015-11
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.46.json
Nutritional Status Moderately Malnourished
active
2025-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.47.json
Nutrition Assessment Status Finding of Moderately Malnourished
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.48.json
Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished
active
2024-01
hl7
1